What is the probability of being too old for salvage transplantation after hepatocellular carcinoma resection?

Digestive and Liver Disease

Volumn 44, Issue 6, 2012, Pages 523-529

  Cucchetti, Alessandro ^a   Cescon, Matteo ^a   Trevisani, Franco ^a   Morelli, Maria Cristina ^a   Ercolani, Giorgio ^a   Pellegrini, Sara ^a   Erroi, Virginia ^a   Bigonzi, Eleonora ^a   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Age; Cirrhosis; Hepatic resection; Hepatocellular carcinoma; Portal hypertension; Salvage transplantation

Indexed keywords

BILIRUBIN;

ADULT; AGE; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MULTIPLE CANCER; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; STATISTICAL MODEL; SURGICAL PATIENT; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

AGE FACTORS; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MARKOV CHAINS; RISK; SALVAGE THERAPY; TIME FACTORS; WAITING LISTS;

EID: 84860250273     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.01.018     Document Type: Article

References (43)

1. El-Serag H.B., Davila J.A., Petersen N.J., et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003, 139:817-823.
2. Thompson Coon J., Rogers G., Hewson P., et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess 2007, 11:1-206.
3. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693-699.
4. Majno P.E., Sarasin F.P., Mentha G., et al. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000, 31:899-906.
5. Cucchetti A., Vitale A., Del Gaudio M., et al. Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant 2010, 10:619-627.
6. Margarit C., Escartín A., Castells L., et al. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transplant 2005, 11:1242-1251.
7. Santi V, Buccione D, Di Micoli A, et al. The changing scenario of hepatocellular carcinoma over the last two decades in Italy. J Hepatol 2011 (July), PMID: 21756850.
8. Fuks D., Dokmak S., Paradis V., et al. Benefit of initial resection of HCC followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology 2012, 55:132-140.
9. Cherqui D., Laurent A., Mocellin N., et al. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 2009, 250:738-746.
10. Llovet J.M., Brú C., Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999, 19:329-338.
11. Forner A., Reig M.E., de Lope C.R., et al. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 2010, 30:61-74.
12. OPTN. 2008 annual report. Available from: [accessed June 15, 2010]. http://www.optn.org/data/annualReport.asp.
13. Guyatt G.H., Sackett D.L., Sinclair J.C., et al. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. J Am Med Assoc 1995, 274:1800-1804.
14. Beck J.R., Kassirer J.P., Pauker S.G. A convenient approximation of life expectancy (the DEALE). I. Validation of the method. Am J Med 1982, 73:883-888.
15. Grazi G.L., Ercolani G., Pierangeli F., et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 2001, 234:71-78.
16. Imamura H., Seyama Y., Kokudo N., et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003, 138:1198-1206.
17. Poon R.T., Fan S.T., Lo C.M., et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002, 235:373-382.
18. Cescon M., Cucchetti A., Grazi G.L., et al. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. Arch Surg 2009, 144:57-63.
19. Park Y.K., Kim B.W., Wang H.J., et al. Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class a patients with cirrhosis. Transplant Proc 2009, 41:1691-1697.
20. D'Amico G., Garcia-Tsao G., Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006, 44:217-231.
21. Llovet J.M., Fuster J., Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999, 30:1434-1440.
22. Lü M.D., Kuang M., Liang L.J., et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006, 86:801-805.
23. Ueno S., Sakoda M., Kubo F., et al. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 2009, 16:359-366.
24. Tanaka S., Noguchi N., Ochiai T., et al. Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting Milan criteria: rationale for partial hepatectomy as first strategy. J Am Coll Surg 2007, 204:1-6.
25. Ishizawa T., Hasegawa K., Aoki T., et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 2008, 134:1908-1916.
26. Adam R., Azoulay D., Castaing D., et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy. Ann Surg 2003, 238:508-518.
27. Del Gaudio M., Ercolani G., Ravaioli M., et al. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant 2008, 8:1177-1185.
28. Ikegami T., Shimada M., Imura S., et al. The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria. Transplantation 2008, 86:641-646.
29. Belghiti J., Cortes A., Abdalla E.K., et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003, 238:885-892.
30. UNOS/OPTN. Modifications to policy 3.6.4.4 (Liver candidates with hepatocellular carcinoma). 3.6. Allocation of livers. Available at: [last access on 01 July 2009]. http://www.unos.org/PoliciesandBylaws2/policies/docs/policy_8.doc.
31. Volk M.L., Vijan S., Marrero J.A. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant 2008, 8:839-846.
32. Perkins J.D., Halldorson J.B., Bakthavatsalam R., et al. Should liver transplantation in patients with model for end-stage liver disease scores < or =14 be avoided? A decision analysis approach. Liver Transplant 2009, 15:242-254.
33. Amin M.G., Wolf M.P., TenBrook J.A., et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transplant 2004, 10:1468-1475.
34. Sarasin F.P., Majno P.E., Llovet J.M., et al. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology 2001, 33:1073-1079.
35. McGlynn K.A., London W.T. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Clin Gastroenterol 2005, 19:3-23.
36. Cammà C., Giunta M., Andreone P., et al. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol 2001, 34:593-602.
37. Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis 2007, 11:191-207.
38. Schaubel D.E., Guidinger M.K., Biggins S.W., et al. Survival benefit-based deceased-donor liver allocation. Am J Transplant 2009, 9:970-981.
39. Berenguer M. Risk of extended criteria donors in hepatitis C virus-positive recipients. Liver Transplant 2008;14(Suppl. 2):S45-50.
40. Barber K., Blackwell J., Collett D., et al. Life expectancy for adult liver allograft recipients in the UK. Gut 2007, 56:279-282.
41. Neuberger J. What is the real gain after liver transplantation? Liver Transplant 2009;(November (Suppl. 2)):S1-5.
42. Cillo U., Vitale A., Volk M.L., et al. The survival benefit of liver transplantation in hepatocellular carcinoma patients. Dig Liver Dis 2010, 42:642-649.
43. Rahbari N.N., Mehrabi A., Mollberg N.M., et al. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 2011, 253:453-469.